REGULATION DIFFERENCES IN SUBSETS OF ANTIDNA ANTIBODIES

抗体亚类的监管差异

基本信息

  • 批准号:
    2517358
  • 负责人:
  • 金额:
    $ 1.92万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1996
  • 资助国家:
    美国
  • 起止时间:
    1996-09-01 至 1997-10-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (Adapted from the Applicant's abstract): In mice transgenic for the R4A gamma2b heavy chain of an anti-double stranded (ds) DNA antibody, the transgenic heavy chain can pair with a variety of endogenous light chains to produce anti-dsDNA antibodies of different affinities and fine specificities. We have demonstrated that B-cells producing high affinity transgenic anti-dsDNA antibodies are regulated by anergy and deletion in non-autoimmune transgenic mice, whereas in the NZB/W F1 mouse strain, high affinity transgene encoded anti-dsDNA antibody is present in the serum. B-cell hybridomas have been generated from spleen and bone marrow cells of non-autoimmune and autoimmune transgenic mice. Initial results suggest that there are three subsets of transgenic anti-dsDNA secreting B-cells. One subset secretes a high affinity anti-dsDNA antibody that utilizes a Vk1 light chain and is targeted for anergy. These B-cells display a lack of allelic exclusion. Another subset secretes high affinity anti-dsDNA antibody encoded by non Vk1 light chains. These are targeted for deletion. A third subset secretes low affinity anti-dsDNA antibodies which escape regulation. These cells display intact allelic exclusion. We would like to confirm these results by obtaining additional hybridomas from bone marrow and spleen cells derived from non autoimmune transgenic mice. We would also like to determine why these populations of B-cells are regulated differently and we propose to identify affinity and fine specificity differences among these subsets. We will see if bcl-2 can rescue one or both of the subsets of B-cells secreting high affinity anti-dsDNA antibody. We recently generated mice transgenic for the R4Amu heavy chain transgene. We would like to compare the regulation of B-cells secreting transgenic IgM anti-dsDNA antibody with those secreting transgenic IgG2b anti-dsDNA antibody to determine if signaling mechanisms affecting tolerance induction differ between these two isotypes.
描述(改编自申请人摘要):在小鼠中进行转基因

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

LINDA Ann SPATZ其他文献

LINDA Ann SPATZ的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('LINDA Ann SPATZ', 18)}}的其他基金

Role of EBNA-1 in Eliciting Anti-dsDNA Antibodies
EBNA-1 在引发抗 dsDNA 抗体中的作用
  • 批准号:
    7231592
  • 财政年份:
    2007
  • 资助金额:
    $ 1.92万
  • 项目类别:
THE VIRAL ETIOLOGY OF SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
系统性红斑狼疮 (SLE) 的病毒病因
  • 批准号:
    7164333
  • 财政年份:
    2005
  • 资助金额:
    $ 1.92万
  • 项目类别:
THE VIRAL ETIOLOGY OF SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
系统性红斑狼疮 (SLE) 的病毒病因
  • 批准号:
    6973869
  • 财政年份:
    2004
  • 资助金额:
    $ 1.92万
  • 项目类别:
VIRAL ETIOLOGY OF SYSTEMIC LUPUS ERYTHEMATOSUS
系统性红斑狼疮的病毒病因
  • 批准号:
    6171217
  • 财政年份:
    1999
  • 资助金额:
    $ 1.92万
  • 项目类别:
VIRAL ETIOLOGY OF SYSTEMIC LUPUS ERYTHEMATOSUS
系统性红斑狼疮的病毒病因
  • 批准号:
    6080896
  • 财政年份:
    1999
  • 资助金额:
    $ 1.92万
  • 项目类别:
REGULATION DIFFERENCES IN SUBSETS OF ANTIDNA ANTIBODIES
抗体亚类的监管差异
  • 批准号:
    2077075
  • 财政年份:
    1996
  • 资助金额:
    $ 1.92万
  • 项目类别:
REGULATION DIFFERENCES IN SUBSETS OF ANTIDNA ANTIBODIES
抗体亚类的监管差异
  • 批准号:
    2887260
  • 财政年份:
    1996
  • 资助金额:
    $ 1.92万
  • 项目类别:
REGULATION DIFFERENCES IN SUBSETS OF ANTIDNA ANTIBODIES
抗体亚类的监管差异
  • 批准号:
    2769526
  • 财政年份:
    1996
  • 资助金额:
    $ 1.92万
  • 项目类别:
REGULATION DIFFERENCES IN SUBSETS OF ANTIDNA ANTIBODIES
抗体亚类的监管差异
  • 批准号:
    2664007
  • 财政年份:
    1996
  • 资助金额:
    $ 1.92万
  • 项目类别:
REGULATION DIFFERENCES IN SUBSETS OF ANTIDNA ANTIBODIES
抗体亚类的监管差异
  • 批准号:
    6170233
  • 财政年份:
    1996
  • 资助金额:
    $ 1.92万
  • 项目类别:

相似海外基金

Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
  • 批准号:
    9981001
  • 财政年份:
    2017
  • 资助金额:
    $ 1.92万
  • 项目类别:
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
  • 批准号:
    9751102
  • 财政年份:
    2017
  • 资助金额:
    $ 1.92万
  • 项目类别:
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
  • 批准号:
    9397073
  • 财政年份:
    2017
  • 资助金额:
    $ 1.92万
  • 项目类别:
Characterization of Naturally Occurring Anti-Blood Group Antibody Formation
天然存在的抗血型抗体形成的表征
  • 批准号:
    10223410
  • 财政年份:
    2017
  • 资助金额:
    $ 1.92万
  • 项目类别:
PREVENTING NEUTRALIZING ANTIBODY FORMATION IN MS PATIENTS WITH SC IFN-BETA (REBI
使用 SC IFN-β (REBI) 预防 MS 患者中和抗体形成
  • 批准号:
    7951676
  • 财政年份:
    2008
  • 资助金额:
    $ 1.92万
  • 项目类别:
PREVENTING NEUTRALIZING ANTIBODY FORMATION IN MS PATIENTS WITH SC IFN-β-AL
预防 SC IFN- 多发性硬化症患者中和抗体的形成
  • 批准号:
    7606036
  • 财政年份:
    2006
  • 资助金额:
    $ 1.92万
  • 项目类别:
IMMUNOLOGIC MECHANISM OF INHIBITOR ANTIBODY FORMATION IN HEMOPHILIA
血友病抑制剂抗体形成的免疫学机制
  • 批准号:
    7375053
  • 财政年份:
    2005
  • 资助金额:
    $ 1.92万
  • 项目类别:
IMMUNOLOGIC MECHANISM OF INHIBITOR ANTIBODY FORMATION IN HEMOPHILIA
血友病抑制剂抗体形成的免疫学机制
  • 批准号:
    7201220
  • 财政年份:
    2004
  • 资助金额:
    $ 1.92万
  • 项目类别:
Immunologic Mechanism of Inhibitor Antibody Formation in Hemophilia
血友病抑制剂抗体形成的免疫学机制
  • 批准号:
    6980810
  • 财政年份:
    2003
  • 资助金额:
    $ 1.92万
  • 项目类别:
INHIBITOR ANTIBODY FORMATION IN HEMOPHILIA AND VON WILLEBRAND'S DISEASE
血友病和冯·维勒布兰德病中的抑制剂抗体形成
  • 批准号:
    6419444
  • 财政年份:
    2000
  • 资助金额:
    $ 1.92万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了